Skip to content

Three Quick Facts: Fevertree, Shepherd Neame and Pendragon

Three Quick Facts: Fevertree, Shepherd Neame and Pendragon

Three things you need to know in the financial markets today from investment writer, Tony Cross.

#1. Fevertree: strong overseas sales but costs take toll

Fevertree Drinks [LON:FVR] has this morning published full year results. Global revenues are up 11%, with growth beyond the UK being specifically compelling. However profits are down 9% and margins have taken a 760 bps hit, eroding cash balances and causing management to take a conservative path when it comes to dividends. The business is focused on a series of cost saving measure and whilst sales growth is tipped to continue next year, expectations are for EBITDA to remain broadly flat.

#2. Shepherd Neame interims show upbeat sales demand, dividend hike

Keeping with the drinks industry and Aquis-listed Shepherd Neame [AQSE:SHEP] has interim results out today for the six months to 24th December. The period saw strong consumer demand but was impacted by rising costs which in turn eroded margin. Underlying pre-tax profits advanced by 15% and interim dividends have been increased by a similar amount, rising from 3.5p to 4p.

#3. Motor retailer Pendragon sees good momentum, margins squeezed

Motor retailer Pendragon LON:PDG has full year results out this morning for the period to 31st December. The company noted good momentum despite challenging macroeconomic conditions, with revenues adding 4.7% although profitability was rather less impressive, slipping 26% on a post-tax basis. Management add however that the picture is improved in the first two months of the new financial year with profitability ahead of the comparative and expects a range of operational initiatives to outweigh cost inflation before interest in 2023.

Share this article

Invest with these platforms

Hargreaves Lansdown

IG

Interactive Brokers

Interactive Investor

Charles Stanley

IG

Interactive Brokers

Charles Stanley

Looking for great investing ideas? Get our free newsletter.

This article does not constitute investment advice.  Do your own research or consult a professional advisor.

Learn with our free 'How to' Guides

Our latest in-depth company reports

On the podcast

Sign up for great investing stock tips

Thanks to our Site Partners

Our partners are established, regulated businesses and we are grateful for their support.

Aquis
CME Group
FP Markets
Pepperstone
Schroders

aberdeen
WisdomTree
ARK
Plus500
CMC Markets
Back To Top